Skip to main navigation
Skip to search
Skip to main content
Sort by
Medicine and Dentistry
Tuberculosis
92%
Multidrug Resistant Tuberculosis
77%
Lung Tuberculosis
53%
Tuberculosis Treatment
32%
Rifampicin
28%
Mycobacterium Tuberculosis
21%
Drug Resistant Tuberculosis
20%
Isoniazid
19%
Nucleic Acid Amplification
18%
Genetics
17%
Sputum
17%
Treatment Outcome
16%
Tuberculostatic Agent
15%
Platinum
15%
Chemotherapy
13%
Hazard Ratio
13%
Hemoptysis
12%
Cohort Analysis
12%
Patient Referral
12%
Infection
12%
Lung Cancer
11%
Epidermal Growth Factor Receptor
11%
Short Course Therapy
11%
Pneumonectomy
11%
Observational Study
11%
Nephrotoxicity
11%
Pneumonia
11%
Diseases
10%
Protionamide
9%
Ethambutol
9%
Quinolone Derivative
9%
Recurrence Risk
8%
Adverse Event
8%
Drug Sensitivity
8%
Drug Resistance
8%
Sputum Culture
8%
Directly Observed Therapy
7%
Ofloxacin
7%
Prevalence
7%
Sputum Smear
7%
Retrospective Cohort Study
7%
Factor Analysis
7%
Fistula
7%
Non Small Cell Lung Cancer
7%
Clofazimine
6%
Sputum Examination
6%
Diagnostic Error
6%
Mortality Rate
6%
Liver Toxicity
6%
Atypical Mycobacterium
5%
Pharmacology, Toxicology and Pharmaceutical Science
Tuberculosis
54%
Lung Cancer
37%
Mycobacterium Tuberculosis
32%
Tuberculostatic Agent
20%
Connective Tissue Growth Factor
20%
Epidermal Growth Factor Receptor
18%
Chemotherapy Regimens
18%
Lung Tuberculosis
18%
Lung Adenocarcinoma
17%
Thrombin
17%
Nuclear Factor
17%
Alternative Complement Pathway C3 C5 Convertase
17%
Isoniazid
17%
Rifampicin
15%
Platinum
15%
Chronic Obstructive Lung Disease
14%
Ethambutol
13%
Non Small Cell Lung Cancer
13%
Drug Resistant Tuberculosis
13%
Cohort Study
12%
Drug Resistance
11%
Transcription Factor AP 1
11%
Nephrotoxicity
11%
Mitogen Activated Protein Kinase
11%
Uridine Diphosphate
11%
Corticosteroid
11%
Inducible Nitric Oxide Synthase
8%
Phosphotransferase
8%
Adverse Event
8%
Overall Survival
8%
Pharmacokinetics
8%
Binding Site
7%
Pneumonia
7%
Cisplatin
7%
Prevalence
6%
Agar
6%
Drug Safety
6%
Pyrazinamide
6%
Protein Kinase C
6%
Hepatotoxicity
6%
Quinolone Derivative
6%
Multi-Drug-Resistant Tuberculosis
5%
Ofloxacin
5%
Liver Disease
5%
QT Prolongation
5%
HIV
5%
Recurrence Risk
5%
Mixed Lineage Kinase 3
5%
Toll Like Receptor 2
5%
Staphylococcus Aureus
5%
Nursing and Health Professions
Tuberculosis
100%
Lung Tuberculosis
35%
Drug Resistance
18%
Tuberculostatic Agent
14%
Cohort Analysis
14%
Multi-Drug-Resistant Tuberculosis
11%
Treatment Outcome
11%
Prevalence
9%
Diseases
8%
Comorbidity
8%
Disease Control
8%
Hazard Ratio
7%
Infection
7%
Agar
6%
Quinolone Derivative
6%
Diabetes Mellitus
6%
Nucleic Acid Amplification
6%
Isoniazid
6%
Ethambutol
6%
Intensive Care Unit
5%
Lung Function Test
5%
Psychological Distress Assessment
5%
Human Immunodeficiency Virus Infection
5%
Distress Syndrome
5%
Asthma Control Test
5%
Electrocardiogram
5%
Foreign Born
5%
Six Minute Walk Test
5%
Treatment Interruption
5%
Extrapulmonary Tuberculosis
5%
Short Course Therapy
5%
Lung Resection
5%
QT Prolongation
5%
Gender Difference
5%
Therapy Delay
5%
Hemodialysis
5%
Patient Referral
5%
Triggering Receptor Expressed on Myeloid Cells 1
5%
Clinical Outcome
5%
Rhodococcosis
5%
Glycemic Control
5%
Confidence Interval
5%
Isoniazid Plus Rifampicin
5%
Chronic Disease
5%
